L'Agenzia Europea dei Medicinali ha avviato una
revisione di Tredaptive, Pelzont e Trevaclyn, medicinali che contengono i
principi attivi acido nicotinico e laropiprant.

Patient circuits are used for ventilating critically ill infants with pulmonary interstitial emphysema and infants with respiratory distress syndrome complicated by pulmonary air leaks

The use of unapproved drugs can lead to pump motor stall and cessation
of drug infusion. A cessation of drug infusion may cause serious adverse health consequences, including death.

The product is being marketed to treat arthritis, muscle pain, osteoporosis, bone cancer, and other conditions; laboratory analysis confirmed "WOW" contains prescription drug ingredients that have the potential to cause serious injury.